Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000145114 | SCV000192157 | uncertain significance | Microcephaly 5, primary, autosomal recessive | 2013-02-08 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000214044 | SCV000278794 | uncertain significance | not specified | 2017-09-26 | criteria provided, single submitter | clinical testing | The c.3599-4 A>G variant has not been published as a mutation, nor has it been reported as a benign polymorphism to our knowledge. The NHLBI Exome Sequencing Project reports c.3599-4 A>G was observed in 40/4404 (0.9%) alleles from individuals of African American background. Additionally, the 1000 Genomes Project reports it was observed in 3/448 (0.7%) alleles from individuals of African background and in 1/196 (0.5%) alleles from individuals of Italian background, indicating it may be a rare (benign) variant in these populations. Several in-silico splice prediction models predict that c.3599-4 A>G creates a cryptic acceptor site which may supplant or damage the natural acceptor site and lead to abnormal gene splicing. However, in the absence of RNA/functional studies, the actual effect of this sequence change in this individual is unknown. Therefore, based on the currently available information, it is unclear whether this variant is a pathogenic mutation or a rare benign variant. |
Eurofins Ntd Llc |
RCV000214044 | SCV000339189 | likely benign | not specified | 2016-01-29 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000961914 | SCV001108970 | benign | not provided | 2025-01-29 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000961914 | SCV004125201 | likely benign | not provided | 2022-06-01 | criteria provided, single submitter | clinical testing | ASPM: PP3, BS2 |
Prevention |
RCV003945162 | SCV004766373 | likely benign | ASPM-related disorder | 2019-03-15 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |